A five-gene signature and clinical outcome in non-small-cell lung cancer.
暂无分享,去创建一个
Jeremy J. W. Chen | Chun-Chi Liu | Chih-Yi Chen | Hsuan-Yu Chen | Sung-Liang Yu | Chun-Houh Chen | G. Chang | A. Yuan | Chiou-Ling Cheng | Chien-Hsun Wang | H. Terng | S. Kao | Wing-Kai Chan | Han-Ni Li | Sher Singh | Wei J Chen | Pan‐Chyr Yang | Chih‐Yi Chen | Wei J. Chen
[1] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[2] L. Schwarzfischer,et al. Molecular cloning of a novel macrophage maturation-associated transcript encoding a protein with several potential transmembrane domains. , 1995, Biochemical and biophysical research communications.
[3] Rakesh Agrawal,et al. SPRINT: A Scalable Parallel Classifier for Data Mining , 1996, VLDB.
[4] Aseem Kumar,et al. Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .
[5] J. J. Chen,et al. Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. , 1998, Genomics.
[6] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[7] I. Bièche,et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. , 1999, Clinical chemistry.
[8] Yih-Leong Chang,et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. , 2001, Journal of the National Cancer Institute.
[9] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Shih,et al. Global analysis of gene expression in invasion by a lung cancer model. , 2001, Cancer research.
[11] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Xiong,et al. Recursive partitioning for tumor classification with gene expression microarray data , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[14] S. Ramaswamy,et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. , 2002, Cancer research.
[15] M. Tyers,et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. , 2002, Cancer research.
[16] F. Motoi,et al. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. , 2003, The American journal of pathology.
[17] G. Kundu,et al. Tyrosine Kinase p56lck Regulates Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator through Tyrosine Phosphorylation of IκBα following Hypoxia/Reoxygenation* , 2003, Journal of Biological Chemistry.
[18] G. Legname,et al. The influence of the src‐family kinases, Lck and Fyn, on T cell differentiation, survival and activation , 2003, Immunological reviews.
[19] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[20] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[21] James A Koziol,et al. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] R. Bast,et al. Individualized care for patients with cancer - a work in progress. , 2004, The New England journal of medicine.
[23] Bengt Bergman,et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.
[24] Hua Yu,et al. The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.
[25] G. Kundu,et al. Tyrosine Kinase, p56lck-induced Cell Motility, and Urokinase-type Plasminogen Activator Secretion Involve Activation of Epidermal Growth Factor Receptor/Extracellular Signal Regulated Kinase Pathways* , 2004, Journal of Biological Chemistry.
[26] Y. Yatabe,et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Sridhar Ramaswamy,et al. Translating cancer genomics into clinical oncology. , 2004, The New England journal of medicine.
[28] Ash A. Alizadeh,et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.
[29] Jeremy J. W. Chen,et al. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion , 2005, Oncogene.
[30] J. Weinstein,et al. Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.
[31] P. Dennis,et al. An overview of lung cancer genomics and proteomics. , 2005, American journal of respiratory cell and molecular biology.
[32] Yi-Chen Lin,et al. Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] Michael Thomas,et al. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. , 2005, Cancer research.
[34] J. Hoheisel. Microarray technology: beyond transcript profiling and genotype analysis , 2006, Nature Reviews Microbiology.
[35] Zhong Wen-zhao,et al. Erlotinib in Lung Cancer - Molecular and Clinical Predictors of Outcome , 2006 .
[36] A. Jemal,et al. Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.
[37] D.,et al. Regression Models and Life-Tables , 2022 .